Broadfin Capital, LLC quarter change: USA Everything Else, Sold out
In partnership units, exchange-traded notes and anything else (listed in the US), from the quarter ended 2016-06-30 to 2016-09-30, Broadfin Capital, LLC opened 0 positions, added to 0, reduced 0, sold out of 2 and left 0 unchanged. The largest increase in value was PERNIX THERAPEUTICS HLDGS IN (-$3,565,000); the largest decrease was EGALET CORP (-$7,600,000).
- EGALET CORP: Country of operation —; Class NOTE 5.500 4/0; Shares 2016-06-30 10,000,000; Shares 2016-09-30 0.
- PERNIX THERAPEUTICS HLDGS IN: Country of operation —; Class DBCV 4.250% 4/0; Shares 2016-06-30 15,500,000; Shares 2016-09-30 0.
Two Form 13F-HR filings compared (SEC CIK 1511901): 2016-06-30 (filed 2016-08-15) and 2016-09-30 (filed 2016-11-14). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move; share change is the position change.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| Not available yet | |||